The takeaway
Anheuser Busch Inbev NV ADR shows a moderate seasonal pattern over 10 years of data — strongest in March (+0.8%) and softest in February (−2.7%).
Right now
In July, the stock has risen 60% of years, averaging +0.4%, roughly 1.7 pts behind the S&P 500.
The full picture
Anheuser Busch Inbev NV ADR's most dependable month has been March, higher in 8 of 10 years; February has been its least reliable, up just 40% of the time.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Win rate % | ||||||||||||
| Median return % | ||||||||||||
| 2025 | ||||||||||||
| 2024 | ||||||||||||
| 2023 | ||||||||||||
| 2022 | ||||||||||||
| 2021 | ||||||||||||
| 2020 | ||||||||||||
| 2019 | ||||||||||||
| 2018 | ||||||||||||
| 2017 | ||||||||||||
| 2016 |
Month by month
Across the year the stock has stayed close to the S&P 500 — no single month stands out as a real edge.
“vs S&P” is Anheuser Busch Inbev NV ADR’s average for a month minus the S&P 500’s average for that same month — isolating Anheuser Busch Inbev NV ADR’s own seasonal edge from broad market drift.
Reality check
Over the last 5 years, March has closed higher 100% of the time versus 80% across the last 10 years — the pattern is strengthening.
Figures are the typical (median) March return and how often it rose — the last 5 years versus the last 10(the heatmap’s default window). This verdict stays anchored to that 10-year window even if you zoom the chart, so it never disagrees with the badges above.
In plain English
Strip the year back and a single month does the heavy lifting: March, up in 8 of 10 Marches while the other eleven tend to blur together.
Its average (+0.8%) and median (+1.5%) land within a hair of each other — the tell of steady, year-after-year gains rather than one outlier doing the work. That reliability comes with real swings, mind — even March ranges by 9.2% from year to year, so any single year can land far from the average. Set against the S&P 500, mind, March is close to a wash — the gain mirrors the market more than it beats it. That consistency sets it apart from the field, where the average stock manages March only about 56% of the time.
The strength clusters rather than stands alone — March–May forms a firm stretch that carries much of the year. At the other end of the calendar, February has been the soft spot — the weakest of 5 months that average a loss (−2.7%), and the edge isn't year-round — the stock has trailed the S&P 500 in October, February, and July.
March has now closed higher 5 years running. If anything it has sharpened recently — the last five Marches run ahead of the earlier years.
The takeaway is less about when to buy than what to expect: March aside, the stock's months offer little reliable tilt.
Short answers on the stock's best month (March), its worst (February), and whether it really trades seasonally.
Yes, to a moderate degree. Since 2016 its best month (March, +0.8%) has run well ahead of its worst (February, −2.7%) — the heatmap above shows how steady that gap has been year to year.
March has been the strongest, averaging +0.8% and closing higher in 8 of 10 years since 2016.
It's the weakest, averaging −2.7% — historically a soft spot, though it still varies from year to year.
Explore
These names have the strongest July track records on record — a starting point for comparison.
Before you trade